As the former Director of the Department of Translational Medicine at the Novo Nordisk Foundation, Dr. Paul Franks is a leading expert in precision and translational medicine. In his talk, Dr. Franks explores the current challenges in diabetes and cardiovascular disease. He offers insights into the possibilities in precision medicine for diabetes and cardiovascular disease for more precise and effective treatments in our modern era of medicine.
As the Director of the Department of Translational Medicine at the Novo Nordisk Foundation, Prof Paul Franksis responsible for overseeing philanthropic initiatives in precision and translational medicine. He trained at the University of Cambridge in genetic and molecular epidemiology of cardiometabolic disease and has been a full professor at Lund University and Harvard School of Public Health since 2010. Since 2017, Paul has also been a visiting professor at the University of Oxford. Past roles include deputy director of Lund University Diabetes Center and Vice-President of the Nordic Society of Human Genetics and Precision Medicine. Paul’s contributions include co-chairing the ADA/EASD Precision Medicine in Diabetes Initiative and the NIDDK Heterogeneity of Diabetes Working Group of Council. With a publication record of more than 500 peer-reviewed papers and 250 invited lectures, Paul is recognized as one of the leading experts globally in precision diabetes medicine. Paul’s research interests span early life programming, gene-lifestyle interactions, and precision medicine, focusing on diabetes, obesity and cardiovascular disease. Paul has received prestigious awards including the EASD Rising Star Award, the Swedish Research Council Distinguished Young Researcher Award, The Novo Nordisk 'Leif Groop' Prize for Excellence in Diabetes Research, and an ERC Consolidator award. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at [ Ссылка ]
